These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Acute lymphoblastic leukaemia in a child with cystic fibrosis. Rizzari C; Conter V; Jankovic M; D'Angelo P; Masera G; Costantini D; Bettinelli ME; Giunta AM Haematologica; 1992; 77(5):427-9. PubMed ID: 1483594 [TBL] [Abstract][Full Text] [Related]
45. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061 [TBL] [Abstract][Full Text] [Related]
46. [Acute lymphoblastic leukemia in childhood. A 10-year experience with the DFCI 81-01 protocol]. de Lacerda AF; Chagas M; Neto A; Vieira E; Ribeiro MJ; Pereira F; Ambrósio A; Sousinha M Acta Med Port; 1999; 12(7-11):287-92. PubMed ID: 10707467 [TBL] [Abstract][Full Text] [Related]
47. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type]. López-Hernández MA; Alvarado-Ibarra M; Álvarez-Veral JL; Ortiz-Zepeda M; Guajardo-Leal ML; Cota-Range X Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792701 [TBL] [Abstract][Full Text] [Related]
48. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486). Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM; Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653 [TBL] [Abstract][Full Text] [Related]
49. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method]. Ochocka M; Zelenay E Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658 [No Abstract] [Full Text] [Related]
50. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group]. Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V; Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892 [TBL] [Abstract][Full Text] [Related]
51. Improved treatment results of non-Hodgkin's lymphoma in children: a report from the Children's Cancer and Leukemia Study Group of Japan. Shimizu H; Kikuchi M; Takaue Y; Utsumi J; Takeda T; Fujimoto T Int J Hematol; 1995 Feb; 61(2):85-96. PubMed ID: 7734716 [TBL] [Abstract][Full Text] [Related]
52. Outcome of treatment in adult acute lymphoblastic leukaemia in an Asian population: comparison with previous multicentre German study. Bosco I; Teh A Leukemia; 1995 Jun; 9(6):951-4. PubMed ID: 7596183 [TBL] [Abstract][Full Text] [Related]
54. [Effect of prognostic factors on the course of acute lymphoblastic leukemia in children]. Rokicka-Milewska R; Derulska D; Lewicki Z Pediatr Pol; 1988 Nov; 63(11):703-15. PubMed ID: 3253657 [No Abstract] [Full Text] [Related]
55. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699 [TBL] [Abstract][Full Text] [Related]
56. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience. Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615 [TBL] [Abstract][Full Text] [Related]
57. The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia. Yetgin S; Cetin M Leuk Lymphoma; 2003 Mar; 44(3):489-95. PubMed ID: 12688320 [TBL] [Abstract][Full Text] [Related]
58. Acute lymphoblastic leukemia in infants. Gürgey A; Yetgin S; Cetin M; Gümrük F; Tuncer AM; Tunçbilek E; Hiçsönmez G Turk J Pediatr; 2004; 46(2):115-9. PubMed ID: 15214738 [TBL] [Abstract][Full Text] [Related]
59. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors. Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717 [TBL] [Abstract][Full Text] [Related]
60. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S; Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]